| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |